Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. MolluscumRx, Inc.
WARNING LETTER
•MolluscumRx, Inc.•August 18, 2023

MolluscumRx, Inc. – FDA Warning Letter, Aug 18, 2023

Record Details

The FDA issued a Warning Letter to MolluscumRx after reviewing their website and social media in June 2023, identifying that their "MolluscumRx" and "MolluscumRx Soap" products are unapproved new drugs. Molluscum contagiosum is not amenable to self-diagnosis or treatment, and no legally marketed OTC drugs exist for it. The FDA is particularly concerned as these products are marketed for children, potentially delaying proper medical diagnosis and treatment for a serious condition.

The products are deemed "drugs" under section 201(g)(1) of the FD&C Act due to claims of treating, curing, or mitigating molluscum contagiosum, including statements like "MolluscumRx Works," "Organic Molluscum Treatment," and "Antiviral ingredients." Claims of being "proven safe for use across the body, face and genital areas" and "highly effective in the treatment for curing molluscum contagiosum" were also cited.

These products are not generally recognized as safe and effective (GRASE) and are therefore "new drugs" under section 201(p) of the FD&C Act. Since no FDA-approved application exists for them, their introduction into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act. The company must respond within fifteen working days, outlining corrective actions and preventative measures,

Company
MolluscumRx, Inc.
Inspection date
August 18, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jill P. Furman (Director)
View Company Profile

ID · 7943040b-10af-4702-af14-cc02d0ad391f

Violation Codes5
21.U.S.C. 355(a)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 35521 U.S.C. 331(d)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MolluscumRx, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.